Business Context and Reporting Period
Great Elm Capital Corp. (GECC) filed a Current Report on Form 8-K dated May 6, 2025. The filing announces the execution of an Equity Distribution Agreement to facilitate an "at-the-market" offering of common stock.
Key Financial Metrics and Capital Structure
This filing does not report operational financial results such as revenue, profit, cash flow, or margins. It focuses on capital raising activities and existing debt securities.
- Proposed Equity Offering: Up to $100,000,000 in aggregate offering price of common stock.
- Underwriting Agent: Lucid Capital Markets, LLC.
- Commission Rate: Up to 2.0% of the gross sales price.
- Pricing Constraint: Sales price (net of commission) will not be less than the Net Asset Value (NAV) per share at the time of sale.
- Existing Debt Securities: The company has multiple notes registered on the Nasdaq Global Market, including 5.875% Notes due 2026, 8.75% Notes due 2028, 8.50% Notes due 2029, and 8.125% Notes due 2029.
Material Changes
The primary material change is the establishment of a new distribution mechanism for equity. The Company entered into an agreement allowing it to sell shares from time to time through an agent using commercially reasonable efforts. No specific sales have been executed as of the filing date; the agreement authorizes future sales.
Outlook, Risks, and Contingencies
- NAV Protection: The Adviser or an affiliate may contribute proceeds to ensure sales are not made below the current NAV per share.
- Agent Obligations: The Agent is not required to sell any specific amount of stock.
- Legal Validity: An opinion of Venable LLP regarding the validity of the shares to be issued is filed as an exhibit.
- Regulatory Compliance: Sales are subject to state and federal securities laws and will only occur where lawful.
Investor Verification Checklist
- Verify the current Net Asset Value (NAV) per share to understand the pricing floor for the offering.
- Review the full text of the Equity Distribution Agreement (Exhibit 1.1) for specific termination provisions and indemnification details.
- Monitor future filings for actual sales volumes and proceeds raised under this agreement.
- Assess the impact of potential dilution on existing shareholders given the $100 million authorization.